Data from Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System Metastases

Autor: Andrew D. Seidman, Larry Norton, Catherine Van Poznak, Martin Fleisher, Sujata Patil, Kendrick Tang, Bob T. Li, Margaret M. Kemeny, Elena Pentsova, Elisa de Stanchina, Aki Morikawa

Purpose:Lapatinib and capecitabine cross the blood–tumor barrier in breast cancer brain metastasis but have modest clinical efficacy. Administration of high-dose tyrosine kinase inhibitor has been evaluated in brain metastases and primary brain tum

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::371ae10916e1f0a5af4cedf20f65615e
https://doi.org/10.1158/1078-0432.c.6528221

Adrenal Myelolipoma Masquerading as an Adrenal Malignancy.

Autor: Robinson DA; Icahn School of Medicine at Mount Sinai, Queens Hospital Center, Department of Surgery, 82-68 164th Street, New York, NY 11432, USA., Kemeny M; Icahn School of Medicine at Mount Sinai, Queens Hospital Center, Department of Surgery, 82-68 164th Street, New York, NY 11432, USA., Muchinyi JE; Icahn School of Medicine at Mount Sinai, Queens Hospital Center, Department of Surgery, 82-68 164th Street, New York, NY 11432, USA., Yasin M; Zucker School of Medicine at Hofstra and Northwell, Northwell Health-North Shore University Hospital, Department of Medicine, Division of Endocrinology, 500 Hofstra University Hempstead, New York, NY 11549, USA., Montes NI; Icahn School of Medicine at Mount Sinai, Queens Hospital Center, Department of Surgery, 82-68 164th Street, New York, NY 11432, USA., Tuli S; Ichahn School of Medicine at Mount Sinai- Queens Hospital Center, Department of Radiology, 82-68 164th Street, New York, NewYork 11432, USA., Jaiswal R; Zucker School of Medicine at Hofstra and Northwell, Northwell Health-North Shore University Hospital, Department of Medicine, Division of Endocrinology, 500 Hofstra University Hempstead, New York, NY 11549, USA., Carter A; Zucker School of Medicine at Hofstra and Northwell, Northwell Health-North Shore University Hospital, Department of Medicine, Division of Endocrinology, 500 Hofstra University Hempstead, New York, NY 11549, USA., Derezil MA; Zucker School of Medicine at Hofstra and Northwell, Northwell Health-North Shore University Hospital, Department of Medicine, Division of Endocrinology, 500 Hofstra University Hempstead, New York, NY 11549, USA., Jang H; Icahn School of Medicine at Mount Sinai, Queens Hospital Center, Department of Surgery, 82-68 164th Street, New York, NY 11432, USA., Reich D; Ichahn School of Medicine at Mount Sinai- Queens Hospital Center, Department of Medicine, Division of Endocrinology, 82-68 164th Street, New York, NewYork 11432, USA.

Publikováno v: Case reports in endocrinology [Case Rep Endocrinol] 2022 Jan 17; Vol. 2022, pp. 4044602. Date of Electronic Publication: 2022 Jan 17 (Print Publication: 2022).

Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial.

Autor: Chung HC; Yonsei Cancer Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul, 03722, South Korea. unchung8@yuhs.ac., Arkenau HT; Sarah Cannon Research Institute/University College London, London, UK., Lee J; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Rha SY; Yonsei Cancer Center, Yonsei University College of Medicine, Yonsei University Health System, Seoul, 03722, South Korea., Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea., Wyrwicz L; Centrum Onkologii-Instytut im. M. Sklodowskiej Curie, Warszawa, Poland., Kang YK; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Lee KW; Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea., Infante JR; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, USA., Lee SS; Inje University College of Medicine, Busan, South Korea., Kemeny M; Queens Cancer Center, Mt Sinai School of Medicine, New York, USA., Keilholz U; Charité Comprehensive Cancer Center, Charitéplatz 1, Berlin, Germany., Melichar B; Palacky University Medical School and Teaching Hospital, I.P. Pavlova 6, Olomouc, Czech Republic., Mita A; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, USA., Plummer R; Northern Centre for Cancer Care and Newcastle University, Freeman Hospital, Newcastle upon Tyne, UK., Smith D; Medical Oncology, Bordeaux University Hospital, Bordeaux CEDEX, France., Gelb AB; EMD Serono, Inc, Billerica, USA., Xiong H; EMD Serono, Inc, Billerica, USA., Hong J; EMD Serono, Inc, Billerica, USA., Chand V; EMD Serono, Inc, Billerica, USA.; Present address: AstraZeneca Pharmaceuticals LP, Gaithersburg, USA., Safran H; Brown University, Providence, USA.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Feb 04; Vol. 7 (1), pp. 30. Date of Electronic Publication: 2019 Feb 04.

Caution Ahead: Research Challenges of a Randomized Controlled Trial Implemented to Improve Breast Cancer Treatment at Safety-Net Hospitals.

Autor: Bickell NA; Icahn School of Medicine at Mount Sinai, Metropolitan Hospital Center, New York; Bronx-Lebanon Hospital Center, Jacobi Medical Center, Bronx; Kings County Hospital Center, NYU Lutheran Medical Center, Brooklyn Hospital Center, Brooklyn; Elmhurst Hospital Center, Elmhurst; Queens Cancer Center, Jamaica, NY; Newark Beth Israel Medical Center, Newark, NJ; and The Ohio State University, Columbus, OH., Shah A; Icahn School of Medicine at Mount Sinai, Metropolitan Hospital Center, New York; Bronx-Lebanon Hospital Center, Jacobi Medical Center, Bronx; Kings County Hospital Center, NYU Lutheran Medical Center, Brooklyn Hospital Center, Brooklyn; Elmhurst Hospital Center, Elmhurst; Queens Cancer Center, Jamaica, NY; Newark Beth Israel Medical Center, Newark, NJ; and The Ohio State University, Columbus, OH., Castaldi M; Icahn School of Medicine at Mount Sinai, Metropolitan Hospital Center, New York; Bronx-Lebanon Hospital Center, Jacobi Medical Center, Bronx; Kings County Hospital Center, NYU Lutheran Medical Center, Brooklyn Hospital Center, Brooklyn; Elmhurst Hospital Center, Elmhurst; Queens Cancer Center, Jamaica, NY; Newark Beth Israel Medical Center, Newark, NJ; and The Ohio State University, Columbus, OH., Lewis T; Icahn School of Medicine at Mount Sinai, Metropolitan Hospital Center, New York; Bronx-Lebanon Hospital Center, Jacobi Medical Center, Bronx; Kings County Hospital Center, NYU Lutheran Medical Center, Brooklyn Hospital Center, Brooklyn; Elmhurst Hospital Center, Elmhurst; Queens Cancer Center, Jamaica, NY; Newark Beth Israel Medical Center, Newark, NJ; and The Ohio State University, Columbus, OH., Sickles A; Icahn School of Medicine at Mount Sinai, Metropolitan Hospital Center, New York; Bronx-Lebanon Hospital Center, Jacobi Medical Center, Bronx; Kings County Hospital Center, NYU Lutheran Medical Center, Brooklyn Hospital Center, Brooklyn; Elmhurst Hospital Center, Elmhurst; Queens Cancer Center, Jamaica, NY; Newark Beth Israel Medical Center, Newark, NJ; and The Ohio State University, Columbus, OH., Arora S; Icahn School of Medicine at Mount Sinai, Metropolitan Hospital Center, New York; Bronx-Lebanon Hospital Center, Jacobi Medical Center, Bronx; Kings County Hospital Center, NYU Lutheran Medical Center, Brooklyn Hospital Center, Brooklyn; Elmhurst Hospital Center, Elmhurst; Queens Cancer Center, Jamaica, NY; Newark Beth Israel Medical Center, Newark, NJ; and The Ohio State University, Columbus, OH., Clarke K; Icahn School of Medicine at Mount Sinai, Metropolitan Hospital Center, New York; Bronx-Lebanon Hospital Center, Jacobi Medical Center, Bronx; Kings County Hospital Center, NYU Lutheran Medical Center, Brooklyn Hospital Center, Brooklyn; Elmhurst Hospital Center, Elmhurst; Queens Cancer Center, Jamaica, NY; Newark Beth Israel Medical Center, Newark, NJ; and The Ohio State University, Columbus, OH., Kemeny M; Icahn School of Medicine at Mount Sinai, Metropolitan Hospital Center, New York; Bronx-Lebanon Hospital Center, Jacobi Medical Center, Bronx; Kings County Hospital Center, NYU Lutheran Medical Center, Brooklyn Hospital Center, Brooklyn; Elmhurst Hospital Center, Elmhurst; Queens Cancer Center, Jamaica, NY; Newark Beth Israel Medical Center, Newark, NJ; and The Ohio State University, Columbus, OH., Srinivasan A; Icahn School of Medicine at Mount Sinai, Metropolitan Hospital Center, New York; Bronx-Lebanon Hospital Center, Jacobi Medical Center, Bronx; Kings County Hospital Center, NYU Lutheran Medical Center, Brooklyn Hospital Center, Brooklyn; Elmhurst Hospital Center, Elmhurst; Queens Cancer Center, Jamaica, NY; Newark Beth Israel Medical Center, Newark, NJ; and The Ohio State University, Columbus, OH., Fei K; Icahn School of Medicine at Mount Sinai, Metropolitan Hospital Center, New York; Bronx-Lebanon Hospital Center, Jacobi Medical Center, Bronx; Kings County Hospital Center, NYU Lutheran Medical Center, Brooklyn Hospital Center, Brooklyn; Elmhurst Hospital Center, Elmhurst; Queens Cancer Center, Jamaica, NY; Newark Beth Israel Medical Center, Newark, NJ; and The Ohio State University, Columbus, OH., Franco R; Icahn School of Medicine at Mount Sinai, Metropolitan Hospital Center, New York; Bronx-Lebanon Hospital Center, Jacobi Medical Center, Bronx; Kings County Hospital Center, NYU Lutheran Medical Center, Brooklyn Hospital Center, Brooklyn; Elmhurst Hospital Center, Elmhurst; Queens Cancer Center, Jamaica, NY; Newark Beth Israel Medical Center, Newark, NJ; and The Ohio State University, Columbus, OH., Parides M; Icahn School of Medicine at Mount Sinai, Metropolitan Hospital Center, New York; Bronx-Lebanon Hospital Center, Jacobi Medical Center, Bronx; Kings County Hospital Center, NYU Lutheran Medical Center, Brooklyn Hospital Center, Brooklyn; Elmhurst Hospital Center, Elmhurst; Queens Cancer Center, Jamaica, NY; Newark Beth Israel Medical Center, Newark, NJ; and The Ohio State University, Columbus, OH., Pappas P; Icahn School of Medicine at Mount Sinai, Metropolitan Hospital Center, New York; Bronx-Lebanon Hospital Center, Jacobi Medical Center, Bronx; Kings County Hospital Center, NYU Lutheran Medical Center, Brooklyn Hospital Center, Brooklyn; Elmhurst Hospital Center, Elmhurst; Queens Cancer Center, Jamaica, NY; Newark Beth Israel Medical Center, Newark, NJ; and The Ohio State University, Columbus, OH., McAlearney AS; Icahn School of Medicine at Mount Sinai, Metropolitan Hospital Center, New York; Bronx-Lebanon Hospital Center, Jacobi Medical Center, Bronx; Kings County Hospital Center, NYU Lutheran Medical Center, Brooklyn Hospital Center, Brooklyn; Elmhurst Hospital Center, Elmhurst; Queens Cancer Center, Jamaica, NY; Newark Beth Israel Medical Center, Newark, NJ; and The Ohio State University, Columbus, OH.

Publikováno v: Journal of oncology practice [J Oncol Pract] 2018 Mar; Vol. 14 (3), pp. e158-e167. Date of Electronic Publication: 2018 Jan 03.

Reducing Disparities in Cancer Screening and Prevention through Community-Based Participatory Research Partnerships with Local Libraries: A Comprehensive Dynamic Trial.

Autor: Rapkin BD; Department of Epidemiology and Population Health, Division of Community Collaboration & Implementation Science, Albert Einstein College of Medicine, Bronx, NY, USA., Weiss E; Department of Epidemiology and Population Health, Division of Community Collaboration & Implementation Science, Albert Einstein College of Medicine, Bronx, NY, USA., Lounsbury D; Department of Epidemiology and Population Health, Division of Community Collaboration & Implementation Science, Albert Einstein College of Medicine, Bronx, NY, USA., Michel T; Queens Borough Public Library, Queens, NY, USA., Gordon A; Department of Epidemiology and Population Health, Division of Community Collaboration & Implementation Science, Albert Einstein College of Medicine, Bronx, NY, USA.; Combined Internal Medicine and Pediatrics Residency Program, University of Southern California, Los Angeles, CA, USA., Erb-Downward J; Department of Epidemiology and Population Health, Division of Community Collaboration & Implementation Science, Albert Einstein College of Medicine, Bronx, NY, USA., Sabino-Laughlin E; Queens Borough Public Library, Queens, NY, USA., Carpenter A; Department of Epidemiology and Population Health, Division of Community Collaboration & Implementation Science, Albert Einstein College of Medicine, Bronx, NY, USA., Schwartz CE; DeltaQuest Foundation, Inc., Concord, MA, USA.; Departments of Medicine & Orthopaedic Surgery, Tufts University Medical School, Boston, MA, USA., Bulone L; Queens Cancer Center, Queens, NY, USA., Kemeny M; Queens Cancer Center, Queens, NY, USA.

Publikováno v: American journal of community psychology [Am J Community Psychol] 2017 Sep; Vol. 60 (1-2), pp. 145-159. Date of Electronic Publication: 2017 Sep 15.